Uterus Cancer

A drug used to treat prostate cancer, problems with the endometrium (lining of the uterus), and uterine fibroids (noncancerous growths of the uterus). It is also being studied in the treatment of other conditions and types of cancer. Leuprolide acetate keeps the body from making the hormones luteinizing hormone-releasing hormone (LHRH) and luteinizing hormone (LH). This causes the testicles to stop making testosterone (a male hormone) in men, and the ovaries to stop making estradiol (a form of the hormone estrogen) in women. Leuprolide acetate may stop the growth of cancer cells that need testosterone to grow and stop the growth of endometrial tissue and uterine fibroids. It is a type of gonadotropin-releasing hormone (GnRH) agonist. Also called Eligard and Lupron Depot. US Brand Name(s): Eligard, Lupron Depot. FDA Approved Yes

Leuprorelin may be used in the treatment of hormone-responsive cancers such as prostate cancer and breast cancer. It may also be used for estrogen-dependent conditions such as endometriosis or uterine fibroids. Leuprorelin, also known as leuprolide, is a manufactured version of a hormone used to treat prostate cancer, breast cancer, endometriosis, uterine fibroids, and early puberty, to perform chemical castration of violent sex offenders, or as part of transgender hormone therapy. It is given by injection into a muscle or under the skin.

Leuprolide acetate is approved for palliative treatment of: Prostate cancer that is advanced. Leuprolide acetate is also being studied in the treatment of other types of cancer.